TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients
Titel:
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients
Auteur:
Vicier, Cecile Sfumato, Patrick Isambert, Nicolas Dalenc, Florence Robert, Marie Levy, Christelle Rezai, Keyvan Provansal, Magali Adélaïde, José Garnier, Séverine Guille, Arnaud Carbuccia, Nadine Popovici, Cornel Charafe-Jauffret, Emmanuelle Chaffanet, Max Birnbaum, Daniel Pakradouni, Jihane Bertucci, François Boher, Jean M. Sabatier, Renaud Gonçalves, Anthony